How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Boost your SQL interview readiness with these 35 carefully selected SQL Interview Questions and Answers. Includes real-world ...

"We are justified by our works, not by our words." St. Clement Of Rome, "First Epistle to the Corinthians," c. 96 A.D. “But rather let us hasten with all energy and readiness of mind to perform every ...

The Democracy Works podcast seeks to answer that question by examining a different aspect of democratic life each week — from voting to criminal justice to the free press and everything in between. We ...

U.S. News Insider Tip: Armature Works' popularity is undeniable, which can mean plenty of people. To avoid the biggest crowds, plan to visit about an hour before or after traditional meal times. – ...

Followers want comfort, stability, and solutions from their leaders. But that’s babysitting. Real leaders ask hard questions and knock people out of their comfort zones. Then they manage the resulting ...